| Invasive Acremonium strictum infection in a bone marrow transplant recipient. | |
| | |
MedLine Citation:
|
PMID: 16511397 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
We describe an invasive Acremonium strictum infection in a 9-year-old debilitated bone marrow transplant recipient. Outcome was successful, despite resistance to the amphotericin B that was initially administered. A. strictum was isolated from bone and urine cultures. We summarize data on 15 opportunistic invasive infections caused by Acremonium in pediatric hosts reported thus far in the English language literature. |
| | |
Authors:
|
Spiros Miyakis; Aristea Velegraki; Sophia Delikou; Agapi Parcharidou; Vassilios Papadakis; Vasssiliki Kitra; Ioannis Papadatos; Sophia Polychronopoulou |
Related Documents
:
|
8891557 - Bone marrow transplantation in chronic granulomatous disease. 8488547 - Pure red cell aplasia following abo-incompatible bone marrow transplantation: response ... 19078807 - Paraproteinemic neuropathies. 17890417 - Stabilization of juvenile metachromatic leukodystrophy after bone marrow transplantatio... 7878747 - Retransplantation after renal allograft loss due to noncompliance. indications, outcome... 10301697 - A consultant's guide to renal dialysis units. |
Publication Detail:
|
Type: Case Reports; Journal Article; Review |
Journal Detail:
|
Title: The Pediatric infectious disease journal Volume: 25 ISSN: 0891-3668 ISO Abbreviation: Pediatr. Infect. Dis. J. Publication Date: 2006 Mar |
Date Detail:
|
Created Date: 2006-03-02 Completed Date: 2006-05-10 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 8701858 Medline TA: Pediatr Infect Dis J Country: United States |
Other Details:
|
Languages: eng Pagination: 273-5 Citation Subset: IM |
Affiliation:
|
Third Department of Medicine, University of Athens, Sotiria General Hospital, Greece. miyakis@hotmail.com |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Acremonium
/
classification,
drug effects,
isolation & purification* Antifungal Agents / therapeutic use Bone Marrow Transplantation / adverse effects* Child Female Humans Male Mycoses / drug therapy*, microbiology Opportunistic Infections / drug therapy*, microbiology Osteomyelitis / drug therapy*, microbiology Pyrimidines / therapeutic use Tibia / microbiology Triazoles / therapeutic use Urine / microbiology |
| Chemical | |
Reg. No./Substance:
|
0/Antifungal Agents; 0/Pyrimidines; 0/Triazoles; 0/voriconazole |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Severe sulfadiazine hypersensitivity in a child with reactivated congenital toxoplasmic chorioretini...
Next Document: Inhaled tobramycin-associated hearing loss in an adolescent with renal failure.